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ABSTRACT: The Bacillus cereus group consists of eight very closely related species and
comprises both harmless and human pathogenic species such as Bacillus anthracis, Bacillus
cereus, and Bacillus cytotoxicus. Numerous eﬀorts have been undertaken to allow presumptive
diﬀerentiation of B. cereus group species from one another. However, methods to rapidly and
accurately distinguish these species are currently lacking. We conﬁrmed that classical matrix-
assisted laser desorption/ionization-time-of-ﬂight (MALDI-TOF) biotyping cannot achieve
reliable identiﬁcation of each type strain. We therefore assigned type strain-speciﬁc
diagnostic peptides to the B. cereus group based on comparisons of their proteomic proﬁles.
The number of diagnostic peptides varied remarkably in a type strain-dependent manner.
The accuracy of the reference database was crucial to validate candidate diagnostic peptides
and led to a noteworthy reduction of veriﬁed diagnostic peptides. Diagnostic peptides
ranged from one for B. weihenstephanensis to 62 for B. pseudomycoides and were associated
with proteins involved in diverse biological processes, e.g. amino acid biosynthesis, cell
envelope, cellular processes, energy metabolism, and transport processes. However, 45.6% of all diagnostic peptides comprised
currently unclassiﬁed proteins or proteins of unknown function. In addition, a phylogenetic tree based on clustering of theoretical
precursor masses deduced from in silico-generated tryptic peptides was reconstructed.
KEYWORDS: Bacillus cereus group, type strains, diagnostic peptides, mass spectrometry
■ INTRODUCTION
The Bacillus cereus group species are Gram-positive, endospore-
forming bacteria, which comprise B. anthracis, B. cereus, B.
cytotoxicus, B. mycoides, B. pseudomycoides, B. thuringiensis, B.
toyonensis, and B. weihenstephanensis.1−4 Despite low genetic
diversity,5−7 they diﬀer remarkably in their medical and public
health importance.8,9 Methods to rapidly and accurately
diﬀerentiate these species are currently lacking. Hence, the
ﬁelds of clinical, environmental, and food microbiology, as well
as biodefense would beneﬁt from a reliable, rapid, and eﬃcient
technique to diﬀerentiate these species.
Bacillus cereus (sensu stricto) exists ubiquitously in nature and
acts as an opportunistic pathogen.10−12 This species is
associated with food poisoning by causing either emetic or
diarrheal syndromes due to the ingestion of the cyclic and heat-
stable toxin cereulide or the production of enterotoxins.13−16
Guinebretier̀e et al. (2013)2 have classiﬁed B. cytotoxicus as a
novel species of the B. cereus group and described its occasional
association with food poisoning. Bacillus cereus (sensu stricto)
and B. cytotoxicus pose a potential threat to the public health via
food industry and agriculture, as contamination with their
spores or vegetative cells may (I) harm the consumers’ health,
in worst case even lead to fatalities,2,17 (II) result in lost
revenue, and (III) damage reputation. Bacillus anthracis can be
detrimental to both animal and human health and has been
abused in bioterrorism.18 Infected people may develop diﬀerent
disease forms of anthrax (cutaneous, gastrointestinal, and
inhalational), which can be fatal if untreated.8,19 On the
contrary, B. thuringiensis received attention due to its ability to
produce crystalline toxins exhibiting insecticidal activity.20
Accordingly, this microorganism has industrial application as
a biological pesticide and its molecular genetics served as a basis
for the bioengineering of transgenic plants and for plant-
associated bacteria such as Pseudomonas f luorescens.21,22
However, certain B. thuringiensis isolates have also been linked
to human cutaneous infections.23 Bacillus weihenstephanensis can
grow below 7 °C24,25 and occasionally encodes the emetic toxin
cereulide.26,27 The combination of these two characteristics
may pose a problem from a food safety perspective. The
remaining B. cereus group species, that is, B. mycoides, B.
pseudomycoides, and B. toyonensis, are considered to be
nonpathogenic organisms.24,28,29 Bacillus mycoides and B.
pseudomycoides are easily recognized by their rhizoidal colonial
growth,28,29 whereas they diﬀer from each other in their fatty
acid proﬁles.29 Bacillus toyonensis has formerly been used as
probiotic strain in animal nutrition (for a detailed historical
report see Jimeńez, Uridain et al. (2013)3).
Numerous molecular studies investigating whole-genome
DNA hybridization,30 sequences of 16S and 23S rRNA genes as
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well as single nucleotide polymorphisms (SNPs) in the
intergenic 16S-23S rRNA regions,31−34 pulsed-ﬁeld gel electro-
phoresis (PFGE),35 multilocus enzyme electrophoresis,6
genomic mapping and rep-PCR ﬁngerprinting,36,37 multilocus
sequence typing (MLST),5,38 and ampliﬁed fragment length
polymorphism (AFLP)39 have revealed pronounced genomic
similarities. Various biochemical assays and immunoassays
allow presumptive diﬀerentiation of B. cereus group species
from one another.8 However, these conventional molecular and
immunological-based identiﬁcation and classiﬁcation techni-
ques are time-consuming and expensive, and require a
combination of several tests. Matrix-assisted laser desorption/
ionization-time-of-ﬂight (MALDI-TOF) biotyping is a valuable
and well-established technique to rapidly identify bacterial
species.40−43 As the members of the B. cereus group are
genetically very similar,5 MALDI biotyping results are reliable
on genus but not on species level.44 Furthermore, mass spectra
quality depends on the physiological state of the bacilli as
progression of sporulation; that is, the presence of spores, can
suppress several of the few characteristic mass ions.45,46
The objective of this study was to assign type strain-speciﬁc
diagnostic peptides to the various members of the B. cereus
group. We analyzed in silico-generated tryptic peptides to
estimate the potential number of type strain-speciﬁc diagnostic
peptides and reconstructed a phylogenetic tree based on the
clustering of theoretical precursor masses. We applied a rapid
cell extraction procedure47 combined with fast generation of
tryptic peptides using high-intensity focused ultrasound
(HIFU)48,49 to obtain trypsin-digested cell extracts. HIFU
improves the solubilization of proteins50 and enables
proteolytic digestion within 15 min. Proteomes were analyzed
using liquid chromatography electrospray ionization tandem
mass spectrometry (LC−ESI MS/MS). We were limited in
analyzing B. anthracis digests as our institute does not have the
infrastructure appropriate for biosafety level 3 facilities. The
relevant quantity and quality of entries, including the correct
classiﬁcation of microorganisms, available on public databases
are crucial for the present study. We veriﬁed the nominated
candidate peptides twice within the theoretical background
provided by the entries on Universal Protein Resource
(UniProt, www.uniprot.org, status of May and October
2015),51 because within six months, the addition of new
entries on UniProtKB challenged the theoretical uniqueness of
diagnostic peptides mainly from B. toyonensis. Comparing the
number of candidate diagnostic peptides with the number of
veriﬁed diagnostic peptides revealed that a remarkable decrease
ranging from 26.3% for B. cytotoxicus to 99.6% for B.
weihenstephanensis occurred.
■ MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Seven type strains of the B. cereus group were investigated.
Bacillus cereus (DSM 31), B. cytotoxicus (DSM 22905), B.
mycoides (DSM 2048), B. pseudomycoides (DSM 12442), B.
thuringiensis (DSM 2046), and B. weihenstephanensis (DSM
11821) were obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ). Bacillus toyonensis
(CECT 876) was kindly provided by Guillermo Jimeńez.3 All
strains were grown aerobically in nutrient broth (5 g/L peptone
from soymeal (Merck, Darmstadt, Germany), 3 g/L meat
extract (Sigma-Aldrich, St. Louis, USA), adjusted to pH 7.0
with NaOH) for approximately 16 h at 30 °C or at 37 or 25 °C
for B. cytotoxicus and B. mycoides, respectively. To ensure
homogeneous suspension of B. mycoides and B. pseudomycoides
in liquid cultures, cells were cultured in baﬄed 250 mL-ﬂasks
(Schott Duran, Mainz, Germany) containing 30 mL nutrient
broth media. The other strains were grown in 5 mL nutrient
broth media at the conditions mentioned above at 220 rpm.
Analysis of in Silico-Generated Tryptic Peptides
Proteomes from the eight type strains of the B. cereus group
available on Universal Protein Resource (UniProt, www.
uniprot.org) (status of September 2015) were in silico analyzed
using R (version 3.1.2).52 Tryptic peptides (without missed
cleavages) and their corresponding peptide masses were
generated using the R language with some additional packages
such as “cleaver” from bioconducter repository,53 “SeqInR”,54
and “protViz”55 from CRAN library. The heat map with
dendrograms for the hierarchical clustering based on accurate
theoretical precursor masses for in silico-generated tryptic
peptides was created using the “gplots” package from CRAN
library.56
Identiﬁcation of Diagnostic Peptides and Classical
Biotyping
All chemicals were of analytical grade and were purchased from
either Sigma-Aldrich (St. Louis, USA), Biosolve (Valkenswaard,
Netherlands), or Merck (Darmstadt, Germany) if not indicated
otherwise.
Protein Extraction
For each type strain, two technical replicates of three
independent biological replicates containing approximately
108 CFU/mL were prepared by ethanol/formic acid extraction
according to the Bruker biotyping protocol.47 Brieﬂy, 1 mL of
bacterial overnight culture (adjusted to approximately 108
CFU/mL) was collected at 5000g for 5 min and washed
once with 1 mL of Milli-Q water. The pellet was resuspended in
75% ethanol (EtOH) and centrifuged at 16100g for 2 min.
EtOH was discarded and any residual solution was evaporated
at room temperature for 5−10 min. The pellet was mixed
thoroughly with 100 μL of 70% formic acid (FA) to disrupt the
cell walls. The sample was incubated for at least 5 min in FA
before the addition of 100 μL of acetonitrile (ACN). The
protein-containing supernatant was separated from the cell
debris and used for (I) classical biotyping and (II) identiﬁcation
of diagnostic peptides.
MALDI-TOF Measurement
Each extract (1 μL) was spotted in triplicates onto a MALDI
target (MSP 96 polished steel BC target; Bruker Daltonics,
Bremen, Germany). After drying, the sample spots were
covered with 1 μL of α-cyano-4-hydroxycinamic acid (Bruker
Daltonics) solution at a concentration of 10 mg/mL in ACN−
water−triﬂuoroacetic acid (50:47.5:2.5 [vol/vol/vol]). MALDI
mass spectra were acquired using a microﬂex LT MALDI-TOF
mass spectrometer (Bruker Daltonics). The following instru-
ment parameters were chosen as suggested by the manufacturer
and as described in ref 48: laser frequency of 60 Hz in the
positive linear mode with an acquisition range of m/z = 2000 to
20000. Final spectra represented the sum of 240 shots per spot
(40 shots per raster spot and random laser movement) using a
laser intensity of approximately 40−50% with a global laser
attenuator oﬀset of 22% resulting in maximal absolute peak
intensities between (3−6) × 104 arbitrary units. Classiﬁcation
was performed using the Realtime Classiﬁcation Biotyper
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software (version 3.1) (Bruker Daltonics) containing 5627
MSPs in the MALDI Biotyper DB (V4.0.0.1).
Trypsin Digestion
To identify type strain-speciﬁc diagnostic peptides, the residual
protein-containing supernatants (190 μL) were evaporated to
dryness using a SpeedVac concentrator (Savant, Thermo
Scientiﬁc, San Jose, USA). Proteins were resolubilized in 5
μL of ACN and 40 μL of Tris-CaCl2 (10 mM, 2 mM, pH = 8.2)
with assistance of high-intensity focused ultrasound (HIFU,
UTR200 reactor, Hielscher, Teltow, Germany) for 5 min, at
75% intensity, 0.6 s cycle time, and a ﬁnal water temperature of
26−29 °C. Five μL of 100 ng/μL trypsin (Roche Diagnostics,
Mannheim, Germany) in 10 mM HCl were added to digest the
proteins using HIFU assistance for 15 min, 75% intensity, 0.6 s
cycle time, and a ﬁnal water temperature of 38−40 °C. The
digestion reaction was stopped by addition of 2 μL of 1 M HCl.
Samples were evaporated to dryness with a SpeedVac
concentrator and stored at −20 °C until further analysis.
LC−MS/MS Analysis
Digested samples were resolubilized in 20 μL of 0.1% FA with
assistance of an ultrasound bath for 1 min and thorough
vortexing and were analyzed on a nanoAcquity UPLC (Waters
Inc., Milford, USA) connected to a Q Exactive mass
spectrometer (Thermo Scientiﬁc) equipped with a Digital
PicoView source (New Objective, Woburn, USA). An aliquot
of 2 μL was injected. Peptides were trapped on a Symmetry
C18 trap column (5 μm, 180 μm × 20 mm, Waters, Inc.) and
separated on a BEH300 C18 column (1.7 μm, 75 μm × 150
mm, Waters Inc.) at a ﬂow rate of 250 nL/min using a gradient
from 1% solvent B (0.1% FA in ACN)/99% solvent A (0.1%
FA in water) to 40% solvent B/60% solvent A within 90 min.
Full scan MS spectra were acquired in positive proﬁle mode
from m/z 350 to m/z 1500 with an automatic gain control
target of 3 × 106, an Orbitrap resolution of 70000 (at m/z 200),
and a maximum injection time of 100 ms. The 12 most intense
multiply charged (z ≥ +2) precursor ions from each full scan
were selected for higher-energy collisional dissociation (HCD)
with a normalized collision energy of 25 (arbitrary unit).
Generated fragment ions were scanned with an Orbitrap
resolution of 35000 (at m/z 200), an automatic gain control
value of 1 × 105, and a maximum injection time of 120 ms. The
isolation window for precursor ions was set to m/z 2.0 and the
underﬁll ratio was at 3.5% (referring to an intensity threshold of
2.9 × 104). Each fragmented precursor ion was set onto the
dynamic exclusion list for 40 s.
Data Analysis
Peak lists in Mascot generic ﬁle (MGF) format were generated
using Proteome Discoverer (v1.4) by picking the 10 most
intense peaks/100 Da and the MGF ﬁles were generated using
the FGCZ Converter Control.57 These were searched against a
Bacillus-speciﬁc database which is composed of 113 bacilli
proteomes (forward and reversed for target-decoy false
discovery rate (FDR) estimation) with 1158177 bacilli protein
sequences (Supplementary Table S-1) available on UniProt
(www.uniprot.org, status of May 2015) using Mascot search
engine (version 2.4.1, Matrix Science Ltd., London, UK). The
search was restricted to tryptic peptides with variable
methionine oxidation and variable asparagine and glutamine
deamidation, precursor mass tolerance of 10 ppm, fragment
mass tolerance of ±0.04 Da, and maximum one missed
cleavage. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org) via the PRIDE partner
repository58 with the data set identiﬁer PXD003669 and
10.6019/PXD003669.
Identiﬁcation of Candidates and Veriﬁcation of Diagnostic
Peptides
Proteomics data were validated using Scaﬀold software (version
4.4.1.1, Proteome Software, Portland, USA) with the following
settings: protein threshold at 2.0% false discovery rate (FDR);
peptide threshold at 1.0% FDR; and two peptides minimum.
The peptide report was exported and candidate peptides were
selected by creating a pivot table in Microsoft Excel 2013
(Supplementary Table S-2). Peptides were nominated as
candidates if they (I) did not contain any missed cleavages,
(II) occurred in all three biosamples of a type strain, and (III)
were not detected in any sample of the other six type strains
examined. Candidates were veriﬁed using R (version 3.2.1) by
conﬁrming that the diagnostic peptide sequences were uniquely
present in one particular Bacillus species and absent in all the
other Bacillus species listed in the above-mentioned Bacillus-
speciﬁc database by string comparison. By October, new entries
on UniProt demanded a second validation step. Candidate
peptides were blasted against the UniProtKB database using the
following parameters: expectation value threshold of 0.0001;
auto assignment of the matrix; no ﬁltering; no gaps; 1000 hits.
If no hits were found for the query, previously assigned protein
identities were allowed to retrieve and blast the entire protein
sequence data in FASTA format against the UniProtKB
database using the search parameters mentioned above.
■ RESULTS
Determination of Bacillus cereus Group Type
Strain-Speciﬁc Diagnostic Peptides
To identify type strain-speciﬁc diagnostic peptides of the B.
cereus group (B. cereus, B. cytotoxicus, B. mycoides, B.
pseudomycoides, B. thuringiensis, B. toyonensis, and B. weihen-
stephanensis), we extracted proteins from 1 mL overnight liquid
cultures containing approximately 108 CFU/mL, digested the
extracts with trypsin using HIFU, and analyzed the proteolytic
samples with a Q Exactive Hybrid Quadrupole-Orbitrap mass
spectrometer. Three independent biological replicates were
analyzed for each type strain. Experimentally unique peptides
were nominated as candidate diagnostic peptides if they (I) did
not contain any missed cleavages, (II) occurred in all three
independent replicates of a type strain, and (III) were not
detected in any of the other type strains investigated (Table 1).
A total of 6129 individual proteins were detected at least once
among all type strains and replicates. A list of all proteins
identiﬁed is provided in the Supporting Information Table S-2
(protein name, accession number, identiﬁcation probability,
sequence coverage, and other relevant information), where
candidate diagnostic peptides are highlighted in light gray.
Table S-2 also summarizes information on peptide identi-
ﬁcation (sequence match, Mascot scores, peptide identiﬁcation
probability, and charge).
Candidate diagnostic peptides were blasted against a Bacillus-
speciﬁc database composed of 113 proteomes downloaded
from Universal Protein Resource (UniProt, www.uniprot.org)
in May 2015 (consult Supporting Information Table S-1 for an
overview of the proteomes downloaded). If the sequence of
candidate diagnostic peptide was not present in any theoretical
proteome of another Bacillus species, its validity was accepted.
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Blasting was performed at two diﬀerent time points, May and
October 2015, resulting in a noteworthy reduction of the
absolute number of validated diagnostic peptides. The values
3.4%, 73.7%, 0.7%, 4.8%, 15.2%, 10.4%, and 0.4% denote the
ratios of the number of veriﬁed diagnostic peptides versus the
number of candidate diagnostic peptides for B. cereus, B.
cytotoxicus, B. mycoides, B. pseudomycoides, B. thuringiensis, B.
toyonensis, and B. weihenstephanensis, respectively (Table 1).
New entries on UniProt Knowledgebase, predominately the
addition of newly submitted proteomes from putative B. cereus
strains, challenged the theoretical uniqueness of the veriﬁed
diagnostic peptides from B. toyonensis. Böhm et al. (2015)7
suggested to review the aﬃliations of certain Bacillus strains as
their classiﬁcation did not match the genomic relationships
presented in their study. Böhm and co-workers7 developed
phylogenetic networks based on average nucleotide identity
(ANI) from genome sequences and whole-genome SNP
analysis subdividing B. cereus sensu lato into seven phylogenetic
groups. These authors suggested renaming all isolates
belonging to the phylogenetic group V as B. toyonensis species,
which allows the validation of seven from the nine diagnostic
peptides assigned to B. toyonensis in May 2015 (Table 1 and
Table S-3).
All diagnostic peptides validated in October 2015 are listed in
Table S-3, whereas Table 2 groups the associated proteins
containing at least one diagnostic peptide according to their
TIGR (The Institute for Genomic Research) function roles.
Figure 1 depicts the workﬂow of our binary approach to
identify type strain-speciﬁc diagnostic peptides.
MALDI-TOF Analysis (Classical Biotyping)
Before LC−MS/MS analysis, MALDI-TOF MS mass spectra
were obtained for each cell extract in triplicates. Certain type
strains of the B. cereus group cannot reliably be distinguished
using classical MALDI-TOF MS biotyping based on the Bruker
Biotyper software (version 3.1) (Table 3). The number of
proteins detected by classical MALDI biotyping ranged from 40
to 54 in a mass range of m/z = 3000 to 20000. By performing
LC−MS/MS analysis, about 45 to 80 times more proteins
could be detected.
Phylogenetic Tree Reconstruction Based on Analysis of
Reference Proteomes of the Type Strains from the B.
cereus Group
We predicted the number of putative unique tryptic peptides in
silico due to the low genetic diversity of the species belonging to
the B. cereus group5 and technical limitations in the analysis of
B. anthracis (Table 4). We only considered mass spectrometry
compatible peptides in a mass range of 500 to 6000 Da that did
not contain the amino acids methionine or cysteine. A list of all
in silico-generated candidate diagnostic peptides is provided in
Supporting Information Table S-4. Theoretical tryptic peptides
of reference proteomes from the eight type strains available on
UniProt were analyzed using R language. We reconstructed a
phylogenetic tree based on theoretical precursor masses (Figure
2).
■ DISCUSSION
Bacillus cereus group members are genetically very closely
related,5−7 however they diﬀer remarkably in terms of their
medical and public health implications.8 In this study, we have
identiﬁed type strain-speciﬁc diagnostic peptides to provide the
basis for the development of a diagnostic tool to diﬀerentiate B.
cereus group species. The diagnostic peptides are associated
with various proteins involved in diverse biological processes.
Grouping of the associated proteins according to TIGR role
categories exempliﬁes the large variety of those processes
(Table 2). The categories cell envelope, cellular processes,
energy metabolism, unclassiﬁed, and unknown function are
covered by at least four of the seven type strains investigated.
The variation of the number of veriﬁed diagnostic peptides per
type strain may be explained by (I) the very high genetic
relatedness of distinct B. cereus group strains combined with
their diﬀerent genome sizes; for example, B. cytotoxicus
comprises ∼3840 proteins, which is ∼1/4 less than the other
type strains, (II) the number of sequenced genomes available
per B. cereus species, (III) not exploiting speciﬁc phenotypic
Table 1. Number of Candidate and Veriﬁed Diagnostic
Peptides for Type Strains of the B. cereus Groupa
species
number of candidate
diagnostic peptides
(detected as
experimentally unique)
veriﬁed diagnostic
peptides
(UniProtKB,
status May 2015)
veriﬁed diagnostic
peptides
(UniProtKB, status
October 2015)
B. ce. 87 6 (6.9%) 3 (3.4%)
B. cy. 19 17 (89.5%) 14 (73.7%)
B. my. 540 73 (13.5%) 4 (0.7%)
B. ps. 1309 81 (6.2%) 62 (4.7%)
B. th. 382 174 (45.5%) 58 (15.2%)
B. to. 67 9 (13.4%) 7 (10.4%)
B. we. 266 2 (0.8%) 1 (0.4%)
aNotation: B. ce., B. cereus; B. cy., B. cytotoxicus; B. my., B. mycoides; B.
ps., B. pseudomycoides; B. th., B. thuringiensis; B. to., B. toyonensis; B. we.,
B. weihenstephanensis.
Table 2. Proteins Containing Veriﬁed Diagnostic Peptides
from Type Strains of the B. cereus Group Grouped
According to TIGR Role Categoriesa
TIGR function roles B. ce. B. cy. B. my. B. ps. B. th. B. to. B. we.
amino acid
biosynthesis
5 1
biosynthesis of
cofactors, prosthetic
groups and carriers
1
cell envelope 1 3 1 2
cellular functions 1
cellular processes 1 2 5 11
DNA metabolism 2 1 1
energy metabolism 1 5 4 2
fatty acid and
phospholipid
metabolism
3
hypothetical proteins 1
protein fate 3 1 1
protein synthesis 1 4
purines, pyrimidines,
nucleosides, and
nucleotides
1 1 1
regulatory functions 2 2 1
transcription 1
transport and binding
proteins
1 6 1
unclassiﬁed 2 2 21 26 1
unknown function 3 1 3 8 1
total 3 14 4 62 58 7 1
aNotation: B. ce., B. cereus; B. cy., B. cytotoxicus; B. my., B. mycoides; B.
ps., B. pseudomycoides; B. th., B. thuringiensis; B. to., B. toyonensis; B. we.,
B. weihenstephanensis.
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characteristics during strain cultivation, that is, psychrotol-
erance (B. weihenstephanensis), rhizoidal growth (B. mycoides
and B. pseudomycoides), thermotolerance (B. cytotoxicus), which
could result in a diﬀerential protein expression proﬁle,25 and
(IV) probable incorrect aﬃliation of individual strains7
deposited on UniProt. Rarely, more than one diagnostic
peptide is found within the same protein. These rare cases are
linked to an ABC transporter (B. pseudomycoides), aromatic
amino acid decarboxylase (B. pseudomycoides), nonribosomal
peptide synthetase C (B. pseudomycoides), cell wall hydrolase
(B. cytotoxicus), and ﬂagellin (B. thuringiensis) and make up
14.1% of all veriﬁed diagnostic peptides (Table S-3). A large
number of veriﬁed diagnostic peptides (45.6%) are associated
with unclassiﬁed proteins or proteins of unknown function.
Veriﬁed diagnostic peptides were not found within homologous
proteins of the diﬀerent type strains with one exception: B.
pseudomycoides as well as B. thuringiensis have veriﬁed diagnostic
peptides that are associated with ﬂagellin (Table S-3). Only one
diagnostic peptide was identiﬁed for B. weihenstephanensis
(Table S-3). We may have lost candidate diagnostic peptides
because we did not grow the cultures at low temperatures and
thus did not exploit a temperature-speciﬁc protein expression
proﬁle of this psychrotolerant species.25 Instead, we chose
comparable culturing conditions for all type strains to facilitate
the development of a simple assay to diﬀerentiate isolates from
the B. cereus group. It is worth mentioning that cells which have
transformed from the vegetative to the sporulative state would
introduce additional signals into the mass spectral protein and
peptide proﬁles. Rapid detection of spores of the respective
species is important, for example, in the investigation of
Figure 1. Workﬂow depicting our main approaches, that is, in silico (green) and wet-lab (blue), to identify B. cereus group type strain-speciﬁc
diagnostic peptides.
Table 3. Comparison of Average Identiﬁcation Scoring Values for B. cereus Group Members Using Classical Biotypinga
species
average score
(best match) SD best match
B. an.
B. ce. 2.384 0.036 18/18 Bacillus cereus DSM 31T DSM
B. cy. 1.848b 0.050 17/18 Bacillus cereus (DSM 31T DSM or 994000168 LBK) 1/18 Bacillus thuringiensis DSM 2046T DSM
B. my. 2.413 0.045 18/18 Bacillus mycoides DSM 2048T DSM (Second best match: 18/18 Bacillus weihenstephanensis DSM 11821T, Average
score: 2.131 ± 0.063)
B. ps. 2.113 0.036 18/18 Bacillus pseudomycoides DSM 12442T DSM
B. th. 2.102 0.077 16/18 Bacillus thuringiensis DSM 2046T DSM 2/18 Bacillus cereus DSM 31T DSM (Average score: 2.065 ± 0.027)
B. to. 2.186b 0.050 17/18 Bacillus cereus DSM 31T DSM (Average score: 2.191 ± 0.046) 1/18 Bacillus thuringiensis DSM 2046T DSM (score:
2.101)
B. we. 2.210 0.112 8/18 Bacillus weihenstephanensis DSM 11821T DSM 9/18 Bacillus mycoides DSM 2048T DSM (Average score:
2.211 ± 0.168) 1/18 Bacillus cereus DSM 31T DSM (Score: 1.841)
aNote: n = 3 independent replicates (prepared in two technical replicates each) were analyzed and spotted in triplicates. SD = standard deviation. B.
an., B. anthracis; B. ce., B. cereus; B. cy., B. cytotoxicus; B. my., B. mycoides; B. ps., B. pseudomycoides; B. th., B. thuringiensis; B. to., B. toyonensis; B. we., B.
weihenstephanensis. bNo entry in current Bruker Taxonomy Database (MALDI Biotyper DB V4.0.0.1).
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bioterrorism agents. The discovery pipeline described in this
work is adaptable also to spore protein extracts. Diagnostic
peptides that are exclusively expressed in spores of certain
Bacillus species were identiﬁed by other groups.59,60
Alternative approaches to distinguish B. cereus group
members on the species level have examined quantitative and
qualitative diﬀerences in fatty acid (methyl esters) proﬁles2,28,29
and cell wall composition proﬁles.61−63 Analyses of glycosyl
components of cell walls have revealed that quantitative
diﬀerences even occurred among very closely related strains,
for example, among several B. anthracis strains.61 On the basis
of ﬁndings of MLST analyses, B. anthracis strains were
identiﬁed to form a homogeneous and clonal cluster within
the B. cereus group.64 Thus, cell wall components may not allow
Table 4. Predicted numbers of Theoretical, Putatively Unique in Silico-Generated Tryptic Peptides of Reference Proteomes
from the Eight Type Strains from the B. cereus Groupa
strain name species
UniProt
Proteome ID reference last modiﬁed
putative no. of unique peptides
(November 2015)
Ames ancestor B. an. UP000000594 Ravel75 September 21,
2015
19420
ATCC 14579/DSM 31/JCM 2152/NBRC 15305/NCIMB
9373/NRRL B-3711
B. ce. UP000001417 Ivanova76 September 21,
2015
11283
NVH 391−98 B. cy. UP000002300 Lapidus77 September 28,
2015
26211
ATCC 6462/DSM 2048 B. my. UP000031884 Johnson78 July 27, 2015 11621
DSM 12442 B. ps. UP000001378 Zwick79 September 28,
2015
36179
ATCC 10792/DSM 2046/CCM 19/NCIB 9134 B. th. UP000001925 Zwick79 September 28,
2015
18864
BCT-7112 B. to. UP000017860 Jimeńez80 September 20,
2015
15731
WSBC 10204/DSMZ 11821 B. we. UP000030313 Stelder25 September 21,
2015
12273
aPeptides were pre-selected according to the limits of LC−ESI MS/MS technique. Peptides were only considered if the peptides (I) lay within an m/
z range of 500−6000 and (II) did not include the amino acids methionine or cysteine. B. an., B. anthracis; B. ce., B. cereus; B. cy., B. cytotoxicus; B. my.,
B. mycoides; B. ps., B. pseudomycoides; B. th., B. thuringiensis; B. to., B. toyonensis; B. we., B. weihenstephanensis.
Figure 2. Heat map and hierarchical clustering with dendrograms for the common precursor masses within the mass range of mass spectrometers
(500 Da−6000 Da) of the eight B. cereus group type strains. The clusterings are generated based on the accurate masses of all the peptides that have
a common precursor mass (rounded to one decimal place) in all type strains. Data analysis was performed using the R language and the following
packages: “cleaver”,53 “protViz”,55 “SeqInR”,54 and “gplots”.56 The Euclidean distance function and method “complete” was used in clustering, which
are default settings in “heatmap.2” of the “gplots” package. The histogram on the top-left of the ﬁgure depicts the frequency of accurate masses in the
data set (light blue line in the histogram, “count”).
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reliable discrimination of distinct B. cereus group members at
the species level. Wang et al. (2015)63 performed whole-cell
proﬁling of surface carbohydrates using atomic force micros-
copy coupled with lectin probes at a single cell level of the B.
cereus type strain (DSM 31). This technique is elusive about the
quantitative detection and distribution of surface carbohydrates
at the single cell level; however, it is limited to targets that have
available speciﬁc binding ligands and it might be more
promising if targets in addition to carbohydrates are considered.
Regarding fatty acid proﬁles, B. cytotoxicus and B. pseudomy-
coides in particular contain diﬀerent amounts of certain major
fatty acids,2,29,65 whereas no speciﬁc pattern or diagnostic
markers could be identiﬁed among the other B. cereus group
species.
Our data support ﬁndings from studies that have revealed
limits of classical MALDI-TOF MS biotyping to discriminate
species belonging to the Bacillus genus45,46 (Table 3). Studies
that have focused on Bacillus classiﬁcation based on MALDI-
TOF MS analysis examined strains predominantly classiﬁed as
B. anthracis, B. cereus, B. thuringiensis, and B. subtilis
species.43,66−70 However, they did not investigate a selection
of strains that would cover all eight species now assigned to the
B. cereus group. We relied on an accurate database to include
proteomes from B. anthracis when verifying the obtained
candidate diagnostic peptides due to experimental limitations.
We constructed a Bacillus-speciﬁc database composed of 113
bacilli proteomes containing 1 158 177 bacilli protein sequences
downloaded from UniProt (www.uniprot.org, status May
2015). Entries on UniProt KB are either reviewed (Swiss-
Prot) or unreviewed (TrEMBL). We included both databases
because Swiss-Prot lacked entries of certain B. cereus group
members (number of entries on Swiss-Prot status December
2015: B. anthracis (3957), B. cereus (4333), B. cytotoxicus (434),
B. mycoides (5), B. pseudomycoides (0), B. thuringiensis (1677), B.
toyonensis (0), and B. weihenstephanensis (434)). We emphasize
the importance of an accurate and comprehensive database and
are aware that we might have falsely excluded candidate
diagnostic peptides from our ﬁnal veriﬁed peptide list because
of incorrect strain aﬃliations of entries in the TrEMBL
database. Since May 2015, the addition of 58 nonredundant
new proteomes predominantly from species classiﬁed as B.
cereus demanded a second veriﬁcation step by repeatedly
blasting the initially veriﬁed diagnostic peptides against the
entire UniProt KB (status of October 2015). We observed a
remarkable decrease in the absolute number of diagnostic
peptides because the query peptide sequence newly clustered
with at least one protein from another B. cereus group species
(Table 1, Table S-2). In the case of B. weihenstephanensis, one
diagnostic peptide remained valid after the second veriﬁcation.
However, we assume that an increasing number of proteomes
available in UniProt KB does not necessarily mean a loss of that
diagnostic peptide. Taking the possible misclassiﬁcation of
microorganisms9 into account, as it has been described before
in case of the B. subtilis group and B. cereus group,7,71,72 we
present our results in the context of the state of art of the
UniProt KB in October 2015 and the proposed review of strain
aﬃliation suggested by Böhm and co-workers.7 It is noteworthy
that subsequent veriﬁcation of diagnostic peptides is required in
the dynamic process of frequent addition of proteomes to
publicly available databases, but also with respect to possible
reclassiﬁcation of strains that have been incorrectly classiﬁed in
the past. Such reclassiﬁcation can lead to regaining previously
excluded diagnostic peptides.
Furthermore, we reconstructed a phylogenetic tree based on
theoretical precursor masses of in silico-generated tryptic
peptides from reference proteomes of the eight B. cereus
type-strains (Figure 2). The heat map shows that the majority
of tryptic peptides that share common m/z values (rounded to
one decimal place) are in the range of 500 to 2500 (see top-left
histogram in Figure 2). Only a few of the peptides that are
shared between all eight species exhibit m/z values greater than
3000. This is obvious as with longer peptide sequences the
chances of introducing a diﬀerent amino acid is more likely.
Here, we were looking only at rounded masses that were found
for all eight species. When taking the accurate m/z values of in
silico-generated tryptic peptides of the eight type-strains into
account, the relatedness among these became apparent.
Clustering on the X-axis therefore revealed a cluster comprising
B. mycoides, B. weihenstephanensis, B. thuringiensis, B. toyonensis,
B. cereus, and B. anthracis which share more common accurate
m/z values among each other as compared to the remaining
species B. cytotoxicus and B. pseudomycoides.
The phylogenetic tree shows a tree topology similar to the
phylogenetic relationships published by Böhm et al.7 In their
study, they generated a phylogenetic master tree from 142 B.
cereus sensu lato strains identifying seven major phylogenetic
clusters as it has been reported previously.73,74 Group I, V, and
VII include B. pseudomycoides, B. toyonensis, and B. cytotoxicus,
respectively. These three species were distinguishable at species
level (ANI border ≥96%), whereas the other ﬁve B. cereus
group species were not assigned to solely one phylogenetic
group.7
In this study, we showed that the B. cereus group type strain-
speciﬁc diagnostic peptides can be detected using LC−MS/MS.
The workﬂow described can be easily adapted to other
microorganisms. It will allow the development of a diagnostic
tool to rapidly and conﬁdently identify bacteria at the level of
species, subspecies, or strains based on targeted monitoring of
diagnostic peptides present in the trypsin-digested protein
extracts. A high-resolution and high mass accuracy selected
reaction monitoring (SRM) assay is the method of choice for
such analyses that will constitute an attractive and cost-eﬀective
alternative or a complement to phenotypic or genotypic
methods in the future.
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